Duncan Wheatley

8.5k total citations
58 papers, 1.1k citations indexed

About

Duncan Wheatley is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Duncan Wheatley has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 23 papers in Cancer Research. Recurrent topics in Duncan Wheatley's work include Breast Cancer Treatment Studies (18 papers), Advanced Breast Cancer Therapies (17 papers) and Cancer Treatment and Pharmacology (14 papers). Duncan Wheatley is often cited by papers focused on Breast Cancer Treatment Studies (18 papers), Advanced Breast Cancer Therapies (17 papers) and Cancer Treatment and Pharmacology (14 papers). Duncan Wheatley collaborates with scholars based in United Kingdom, Spain and United States. Duncan Wheatley's co-authors include Stephen Kelly, Adrian Murray Brunt, Robert E. Coleman, John Yarnold, Judith M. Bliss, Martina Uttenreuther‐Fischer, Charlotte E. Coles, Tamas Hickish, David S. Mendelson and Stephen Houston and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

Duncan Wheatley

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Duncan Wheatley United Kingdom	16	733	367	348	340	145	58	1.1k
Florian Würschmidt Germany	19	330 0.5×	500 1.4×	305 0.9×	316 0.9×	104 0.7×	49	1.0k
Eduardo Jose Stefano Brazil	13	369 0.5×	516 1.4×	206 0.6×	197 0.6×	93 0.6×	22	1.1k
Federica Cuppone Italy	20	1.1k 1.5×	604 1.6×	115 0.3×	388 1.1×	199 1.4×	50	1.5k
A. Ashworth Canada	13	554 0.8×	593 1.6×	118 0.3×	278 0.8×	248 1.7×	26	1.2k
Daniel Serin France	17	1.3k 1.7×	242 0.7×	302 0.9×	808 2.4×	75 0.5×	45	1.6k
Carla Hajj United States	18	551 0.8×	295 0.8×	151 0.4×	148 0.4×	97 0.7×	85	916
Christer Svedman United States	13	228 0.3×	416 1.1×	104 0.3×	332 1.0×	171 1.2×	28	746
Nadia Pasinetti Italy	13	270 0.4×	368 1.0×	160 0.5×	160 0.5×	133 0.9×	38	809
Voichita Bar‐Ad United States	21	514 0.7×	447 1.2×	223 0.6×	230 0.7×	330 2.3×	98	1.4k
Martin Donach Italy	14	606 0.8×	279 0.8×	127 0.4×	157 0.5×	151 1.0×	30	1.1k

Countries citing papers authored by Duncan Wheatley

Since Specialization

Citations

This map shows the geographic impact of Duncan Wheatley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duncan Wheatley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duncan Wheatley more than expected).

Fields of papers citing papers by Duncan Wheatley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duncan Wheatley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duncan Wheatley. The network helps show where Duncan Wheatley may publish in the future.

Co-authorship network of co-authors of Duncan Wheatley

This figure shows the co-authorship network connecting the top 25 collaborators of Duncan Wheatley. A scholar is included among the top collaborators of Duncan Wheatley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duncan Wheatley. Duncan Wheatley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kirby, Anna M., Laura Finneran, Clare Griffin, et al.. (2025). Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial. The Lancet Oncology. 26(7). 898–910.

Pérez-García, José Manuel, Meritxell Bellet, Miguel Gil‐Gil, et al.. (2025). Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial. ESMO Open. 10(7). 105309–105309.

Nabi, Zohal, Patricia Díez, Rashid Mir, et al.. (2025). Regional Lymph Node Delineation variability and its Dosimetric Impact in Breast Cancer Radiotherapy. Clinical Oncology. 42. 103836–103836.

García-Murillas, Isaac, Ros Cutts, Charles W. Abbott, et al.. (2024). Ultra-sensitive ctDNA mutation tracking to identify molecular residual disease and predict relapse in patients with early breast cancer.. Journal of Clinical Oncology. 42(16_suppl). 1010–1010. 8 indexed citations

Symeonides, Stefan N., Duncan Wheatley, Stephen Chan, et al.. (2023). Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study. Breast Cancer Research and Treatment. 199(1). 35–46. 8 indexed citations

Neven, Patrick, Neil Stahl, María Vidal, et al.. (2023). 273P A preoperative window-of-opportunity (WOO) study of imlunestrant in ER+, HER2- early breast cancer (EBC): Final analysis from EMBER-2. Annals of Oncology. 34. S292–S293. 4 indexed citations

Kirby, Anna M., Clare Griffin, Laura Finneran, et al.. (2023). Partial Breast Radiotherapy for Women with Early Breast Cancer: 10-Year Outcomes from IMPORT LOW (CRUK/06/003). International Journal of Radiation Oncology*Biology*Physics. 117(4). e7–e7.

Palmieri, Carlo, A. E. Musson, Catherine Harper‐Wynne, et al.. (2023). A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program. British Journal of Cancer. 129(5). 852–860. 8 indexed citations

Bliss, Judith M., Adrian Murray Brunt, Charlotte E. Coles, et al.. (2022). Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis. Breast Cancer Research and Treatment. 197(2). 405–416. 15 indexed citations

10.

Schmid, Peter, Duncan Wheatley, Pankaj G. Roy, et al.. (2021). 208P ARB: Phase II window of opportunity study of preoperative treatment with enzalutamide in ER+ve and TNBC. Annals of Oncology. 32. S449–S450. 1 indexed citations

11.

Brunt, Adrian Murray, Duncan Wheatley, John Yarnold, et al.. (2016). Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial. Radiotherapy and Oncology. 120(1). 114–118. 149 indexed citations

12.

Ring, Alistair, Duncan Wheatley, Helen Hatcher, et al.. (2014). Phase I Study to Assess the Combination of Afatinib with Trastuzumab in Patients with Advanced or Metastatic HER2-Positive Breast Cancer. Clinical Cancer Research. 21(12). 2737–2744. 16 indexed citations

13.

Barrett‐Lee, Peter, Angela Casbard, Jacinta Abraham, et al.. (2013). Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial. The Lancet Oncology. 15(1). 114–122. 83 indexed citations

14.

Coles, Charlotte E., Adrian Murray Brunt, Duncan Wheatley, M. Mukesh, & John Yarnold. (2012). Breast Radiotherapy: Less is More?. Clinical Oncology. 25(2). 127–134. 18 indexed citations

15.

Miles, David, John Bridgewater, Peter Ellis, et al.. (2010). Using bevacizumab to treat metastatic cancer: UK consensus guidelines. British Journal of Hospital Medicine. 71(12). 670–678. 9 indexed citations

16.

Coleman, Robert E., Matthew Winter, David Cameron, et al.. (2010). The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. British Journal of Cancer. 102(7). 1099–1105. 168 indexed citations

17.

Beable, Richard, et al.. (2009). Entero-caval fistula, a complication following chemoradiotherapy for a rectal carcinoma. Clinical Radiology. 65(1). 85–88.

18.

Kelly, Stephen & Duncan Wheatley. (2009). Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors. British Journal of Cancer. 101(S1). S6–S10. 31 indexed citations

19.

Wheatley, Duncan, Asha Adwani, S. Ebbs, et al.. (2004). Matching supraclavicular fields to the extent of axillary surgery in women prescribed radiotherapy for early stage carcinoma of the breast. Clinical Oncology. 17(1). 32–38. 5 indexed citations

20.

Huwez, Farhad, Philip R. Belcher, V. Pathi, Surendra Naik, & Duncan Wheatley. (1997). Osteonecrosis of the Calcaneum in a Heart Transplant Recipient. The Thoracic and Cardiovascular Surgeon. 45(4). 204–205. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact